Hyponatremia is one of the most frequently encountered electrolyte abnormalities in clinical practice and is associated with significant morbidity and mortality. Among its various forms, hyperglycaemia-induced hyponatremia represents a unique and often reversible subtype characterized by a reduction in measured serum sodium concentration in the presence of elevated plasma glucose levels. This phenomenon is primarily driven by osmotic shifts of water from the intracellular to the extracellular compartment, resulting in dilutional hyponatremia rather than a true deficit of total body sodium. Hyperglycaemia itself is a frequently observed biochemical abnormality and may be detected incidentally during routine laboratory testing in asymptomatic individuals. It can also occur in situations that place increased demand on pancreatic β-cells, such as pregnancy, severe illness, or treatment with medications like corticosteroids, a condition commonly referred to as stress hyperglycaemia. In some cases, however, patients present with acute metabolic emergencies caused by uncontrolled hyperglycaemia, including diabetic ketoacidosis, which requires prompt medical intervention. Understanding the relationship between hyperglycaemia and hyponatremia is clinically important, as the reduction in serum sodium in these cases primarily reflects osmotic fluid shifts rather than actual sodium depletion. Consequently, management should focus on correcting the underlying hyperglycaemia, which typically leads to normalization of serum sodium levels. Recognizing this mechanism helps clinicians avoid unnecessary sodium replacement and guides appropriate treatment strategies for patients with diabetes presenting with electrolyte abnormalities.
| Published in | International Journal of Diabetes and Endocrinology (Volume 11, Issue 1) |
| DOI | 10.11648/j.ijde.20261101.12 |
| Page(s) | 7-12 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2026. Published by Science Publishing Group |
Hyperglycemia, Hyponatremia, Syzygium Jambolanum
Date | Follow up | Prescription | Remarks |
|---|---|---|---|
28/10/2025 | General weakness persists. Pain in right frontal region persist. HBA1C: 9% FBS- 378mg/dl Serum Na+ 130meq/litre. Serum K+ 4 meq/litre. | Rx Syzygium jambolanum 30 (3-3-3) IVF (0.9% saline 100ml/hr.) | |
29/10/2025 | General weakness improved. Pain in right frontal region ameliorated. Serum Na+ 131meq/litre. Serum K+ 4.72meq/litre. FBS--368 mg/dl. | Rx 1. Syzygium jambolanum30 (3-3-3) | |
30/10/2025 | General weakness improved. Pain in right frontal region ameliorated. Serum Na+ 134meq/litre. Serum K+ 4.9meq/litre. FBS-368 mg/dl. | Rx 1. Syzygium jambolanum30 (3-3-3) | |
31/10/2025 | General weakness improved. Pain in right frontal region ameliorated. Serum Na+ 135meq/litre. Serum K+ 5.2meq/litre. FBS-362mg/ dl. | Rx 1. Syzygium jambolanum30 (3-3-3) 2. IVF (0.9% saline 90ml/ hour). 3. Advised for diabetic diet. | |
01/11/2025 | General weakness improved. Pain in right frontal region ameliorated. FBS-358mg/dl. | Rx 1. Syzygium jambolanum30 (3-3-3) | |
02/11/2025 | General weakness improved. Pain in right frontal region ameliorated. FBS-320mg/dl. Serum Na+ 137meq/litre. Serum K+ 5.6meq/litre | Rx 1. Syzygium jambolanum30 (3-3-3) | |
03/11/2025 | General weakness improved. Pain in right frontal region ameliorated. FBS-322mg/dl. | Rx 1. Syzygium jambolanum30 (3-3-3) | |
04/11/2025 | General weakness improved. Pain in right frontal region ameliorated. FBS -291mg/dl. | Rx 1. Syzygium jambolanum30 (3-3-3) | |
05/11/2025 | General weakness improved. Pain in right frontal region ameliorated. FBS – 296mg/dl. | Rx 1. Syzygium jambolanum30 (3-3-3) | |
06/11/2025 | General weakness improved. Pain in right frontal region ameliorated. FBS- 250 mg/l Serum Na+ 138meq/litre. Serum K+ 5.8meq/litre | Rx 1. Syzygium jambolanum30 (3-3-3) |
NO: | Domain | Yes | No | Not sure |
|---|---|---|---|---|
1. | Was there an improvement in the main symptom or condition for which the homoeopathy medicine was prescribed? | +2 | ||
2. | Did the clinical improvement occur within a plausible time frame relative to the medicine intake? | +1 | ||
3. | Was there a homeopathic aggravation of symptoms? | 0 | ||
4. | Did the effect encompass more than the main symptom or condition (i.e., were other symptoms, not related to the main presenting complaint, improved or changed)? | +1 | ||
5. | Did overall well-being improve? (Suggest using a validated scale or mention about changes in physical, emotional, and behavioral elements) | +2 | ||
6 A | Direction of cure: did some symptoms improve in the opposite order of the development of the symptoms of the disease? | +1 | ||
6 B | Direction of cure: did at least two of the following aspects apply to the order of improvement of symptoms: from organs of more importance to those of less importance? from deeper to more superficial aspects of the individual? from the top downwards? | +1 | ||
7. | Did “old symptoms” (defined as non-essential and non-clinical symptoms that were previously thought to have resolved) reappear temporarily during the course of improvement? | +1 | ||
8. | Are there alternative causes (i.e., other than the medicine) that—with a high probability—could have produced the improvement? (Consider known course of disease, other forms of treatment, and other clinically relevant interventions) | 0 | ||
9. | Was the health improvement confirmed by any objective evidence? (e.g., investigations, clinical examination, etc.) | +1 | ||
10. | Did repeat dosing, if conducted, create similar clinical improvement? | +1 | ||
Total score | 11 |
AVP | Arginine Vasopressin |
ECFV | Extracellular Fluid Volume |
| [1] | Piero Portincasa and David Q-H. Wang (2018). Fluid and Electrolyte Disturbances: Harrison’s principles of internal medicine, 21st edition. |
| [2] | Penman ID, Ralston SH, Strachan MWJ, Hobson R, editors. Davidson’s Principles and Practice of Medicine. 24th ed. Elsevier Health Sciences; 2022. |
| [3] | W. Chapman and Jane Collier (2015). Endocrine disorders: Oxford textbook of medicine sixth edition, volume -2: Section 13. |
| [4] | Hall JE. Guyton and Hall textbook of medical physiology. The body fluids and kidneys: 14th ed. Philadelphia: Elsevier; 2021. |
| [5] | Gupta Y. Hyponatremia: a case study with homoeopathic treatment. International Journal of Homoeopathic Sciences. S. K. Homoeopathic Medical College & Research Centre, Sitapura, Jaipur, Rajasthan, India. |
| [6] | Wolf MB. Hyperglycemia-induced hyponatremia: Reevaluation of the Na⁺ correction factor. |
| [7] | McNair P, Madsbad S, Christiansen C, et al. Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients. |
| [8] | Twomey PJ, Cordle J, Pledger DR, Miao Y. An unusual case of hyponatraemia in diabetic ketoacidosis. |
| [9] | Boericke W. Boericke’s New Manual of Homoeopathic Materia Medica with Repertory. Third Revised and Augmented Edition Based on Ninth Edition. New Delhi, India: B. Jain Publishers; 2010. |
| [10] | Allen HC. Keynotes and characteristics with comparisons of some of the leading remedies of the materia medica. New Delhi: B Jain Publishers; 2002. |
| [11] | Clarke JH. A dictionary of practical materia medica. Vol. 1–3. New Delhi: B Jain Publishers; 1999. |
APA Style
Asharaf, A. K., Kadavath, R., Prasannakumari, P. A. P. (2026). Electrolyte Imbalance in Diabetes Mellitus: A Case Report on Homoeopathic Management of Hyperglycemia-induced Hyponatremia. International Journal of Diabetes and Endocrinology, 11(1), 7-12. https://doi.org/10.11648/j.ijde.20261101.12
ACS Style
Asharaf, A. K.; Kadavath, R.; Prasannakumari, P. A. P. Electrolyte Imbalance in Diabetes Mellitus: A Case Report on Homoeopathic Management of Hyperglycemia-induced Hyponatremia. Int. J. Diabetes Endocrinol. 2026, 11(1), 7-12. doi: 10.11648/j.ijde.20261101.12
@article{10.11648/j.ijde.20261101.12,
author = {Ahsan Keepurath Asharaf and Rincy Kadavath and Prajitha Ajithkumaran Pillai Prasannakumari},
title = {Electrolyte Imbalance in Diabetes Mellitus: A Case Report on Homoeopathic Management of Hyperglycemia-induced Hyponatremia},
journal = {International Journal of Diabetes and Endocrinology},
volume = {11},
number = {1},
pages = {7-12},
doi = {10.11648/j.ijde.20261101.12},
url = {https://doi.org/10.11648/j.ijde.20261101.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20261101.12},
abstract = {Hyponatremia is one of the most frequently encountered electrolyte abnormalities in clinical practice and is associated with significant morbidity and mortality. Among its various forms, hyperglycaemia-induced hyponatremia represents a unique and often reversible subtype characterized by a reduction in measured serum sodium concentration in the presence of elevated plasma glucose levels. This phenomenon is primarily driven by osmotic shifts of water from the intracellular to the extracellular compartment, resulting in dilutional hyponatremia rather than a true deficit of total body sodium. Hyperglycaemia itself is a frequently observed biochemical abnormality and may be detected incidentally during routine laboratory testing in asymptomatic individuals. It can also occur in situations that place increased demand on pancreatic β-cells, such as pregnancy, severe illness, or treatment with medications like corticosteroids, a condition commonly referred to as stress hyperglycaemia. In some cases, however, patients present with acute metabolic emergencies caused by uncontrolled hyperglycaemia, including diabetic ketoacidosis, which requires prompt medical intervention. Understanding the relationship between hyperglycaemia and hyponatremia is clinically important, as the reduction in serum sodium in these cases primarily reflects osmotic fluid shifts rather than actual sodium depletion. Consequently, management should focus on correcting the underlying hyperglycaemia, which typically leads to normalization of serum sodium levels. Recognizing this mechanism helps clinicians avoid unnecessary sodium replacement and guides appropriate treatment strategies for patients with diabetes presenting with electrolyte abnormalities.},
year = {2026}
}
TY - JOUR T1 - Electrolyte Imbalance in Diabetes Mellitus: A Case Report on Homoeopathic Management of Hyperglycemia-induced Hyponatremia AU - Ahsan Keepurath Asharaf AU - Rincy Kadavath AU - Prajitha Ajithkumaran Pillai Prasannakumari Y1 - 2026/04/02 PY - 2026 N1 - https://doi.org/10.11648/j.ijde.20261101.12 DO - 10.11648/j.ijde.20261101.12 T2 - International Journal of Diabetes and Endocrinology JF - International Journal of Diabetes and Endocrinology JO - International Journal of Diabetes and Endocrinology SP - 7 EP - 12 PB - Science Publishing Group SN - 2640-1371 UR - https://doi.org/10.11648/j.ijde.20261101.12 AB - Hyponatremia is one of the most frequently encountered electrolyte abnormalities in clinical practice and is associated with significant morbidity and mortality. Among its various forms, hyperglycaemia-induced hyponatremia represents a unique and often reversible subtype characterized by a reduction in measured serum sodium concentration in the presence of elevated plasma glucose levels. This phenomenon is primarily driven by osmotic shifts of water from the intracellular to the extracellular compartment, resulting in dilutional hyponatremia rather than a true deficit of total body sodium. Hyperglycaemia itself is a frequently observed biochemical abnormality and may be detected incidentally during routine laboratory testing in asymptomatic individuals. It can also occur in situations that place increased demand on pancreatic β-cells, such as pregnancy, severe illness, or treatment with medications like corticosteroids, a condition commonly referred to as stress hyperglycaemia. In some cases, however, patients present with acute metabolic emergencies caused by uncontrolled hyperglycaemia, including diabetic ketoacidosis, which requires prompt medical intervention. Understanding the relationship between hyperglycaemia and hyponatremia is clinically important, as the reduction in serum sodium in these cases primarily reflects osmotic fluid shifts rather than actual sodium depletion. Consequently, management should focus on correcting the underlying hyperglycaemia, which typically leads to normalization of serum sodium levels. Recognizing this mechanism helps clinicians avoid unnecessary sodium replacement and guides appropriate treatment strategies for patients with diabetes presenting with electrolyte abnormalities. VL - 11 IS - 1 ER -